Compositions, methods, and systems to detect hematopoietic stem cell transplantation status
AssigneeSequenom, Inc.
InventorsRoy Brian LEFKOWITZ, John Allen TYNAN, Chen XU
Life of this patent
Estimating the term…
Loading patent…
AssigneeSequenom, Inc.
InventorsRoy Brian LEFKOWITZ, John Allen TYNAN, Chen XU
Estimating the term…
This application provides methods and systems for determining transplant status. In some embodiments, the method comprises obtaining a biological sample from hematopoietic stem cell transplant (HSCT) recipient; measuring the amount of one or more identified recipient-specific nucleic acids or donor-specific nucleic acids in the sample; and (c) determining transplant status by monitoring the amount of the one or more identified recipient-specific nucleic acids or donor-specific nucleic acids after transplantation. In some approaches, the one or more recipient-specific or the donor-specific nucleic acids are identified based on the amount of one or more polymorphic nucleic acid targets, which can be used to determine the transplant status. Optionally, the biological sample is blood or bone marrow. Optionally the nucleic acid is genomic DNA.
A method of determining transplant status comprising:
(canceled)
5-6. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
25-27. (canceled)
(canceled)
(canceled)
(canceled)
A system for determining transplantation status comprising one or more processors;
Dependencies are inferred from the claim text.